Dr. Sigrid Hanke Programme Director

Life Sciences 3: Medicine
E-mail: sigrid.ziegler@dfg.de Telephone: +49 (228) 885-2676 Telefax: +49 (228) 885-713320

Kennedyallee 40
53175 Bonn

Tasks

Support of DFG Statutory Bodies
Sektion 3 des Fachkollegiums Medizin

Scientific Areas of Responsibility

Main Contact
2.22-09 Pharmacology
2.22-10 Toxicology, Laboratory Medicine
2.22-12 Cardiology, Angiology
2.22-26 Cardiac and Vascular Surgery
Deputy Contact
2.22-04 Anatomy and Physiology
2.22-13 Pneumology, Thoracic Surgery

Coordinated Programmes (scientific matters)

Exzellenzcluster
2026 Cardio-Pulmonary Institute (CPI)
Graduiertenkolleg
2338 Targets in Toxicology - Deciphering Therapeutic Targets in Lung Toxicology
2381 cGMP: From Bedside to Bench
2578 Impact of genotoxins on the differentiation efficacy of murine and human stem and progenitor cells and functional competence of thereof derived differentiated progeny
2816 Non-canonical G protein signaling pathways: Mechanisms, functions, consequences
2989 Targeting Cellular Interfaces in Reperfused Acute Myocardial Infarction
SFB/Transregio
152 TRiPs to Homeostasis: Maintenance of Body Homeostasis by Transient Receptor Potential Channel Modules
259 Aortic Disease
Sonderforschungsbereich
1002 Modulatory Units in Heart Failure
1039 Signalling by fatty acid derivatives and sphingolipids in health and disease
1123 Atherosclerosis: Mechanisms and Networks of Novel Therapeutic Targets
1366 Vascular Control of Organ Function
1425 Heterocellular Nature of Cardiac Lesions: Identities, Interactions, Implications
1470 Multilevel mechanistic characterisation of Heart Failure with Preserved Ejection Fraction - Towards a novel classification of HFpEF for targeted therapies
1525 Cardio-Immune Interfaces
1550 Molecular Circuits of Heart Disease
992 MEDEP - Medical Epigenetics - from basic mechanisms to clinical applications

Coordinated Programmes (procedural matters)

Klinische Forschungsgruppe
311 Cardiac and pulmonary failure: mechanical unloading andrepair
329 Disease pathways in podocyte injury – from molecular mechanisms to individualized treatment options